Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

Even though Pfizer Inc.'s ( NYSE:PFE ) recent earnings release was robust, the market didn't seem to notice. We ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

A few months after Dr. Orion Mercaitis leased a polo pony from Olivia Stringer in Aiken, S.C., their relationship took off at ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

Cavazzoni previously worked at Pfizer prior to joining the FDA in 2018 ... when President Biden nominated him for the same job. Califf eventually made ethics concessions to Warren to secure ...

We recently published a list of 12 Best Multibagger Stocks to Buy in 2025. In this article, we are going to take a look at ...

WASHINGTON, D.C. U.S. Senate Democratic Whip Dick Durbin (D-IL) sent letters to five telehealth companies that have held ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director of the ...

HHS secretary RFK Jr. said that he would “shut the revolving door to reestablish public trust” in the department.